Pharmacology of Antisense Oligonucleotide Inhibitors of Protein Expression

• Published in: Pharmacology & therapeutics (Oxford) Vol. 82; no. 2; pp. 427 - 435
• Main Authors: Cooper, Scott R., Taylor, Jennifer K., Miraglia, Loren J., Dean, Nicholas M.
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01.05.1999
• Subjects: Antisense oligonucleotides; Forecasting; inhibition; mechanism of action; Oligonucleotides, Antisense - antagonists & inhibitors; Oligonucleotides, Antisense - chemistry; Oligonucleotides, Antisense - therapeutic use; PKC-η; Proteins - chemistry; Proteins - genetics; research tools; RNA Splicing - genetics; splicing; 2′-MOE, 2′-methoxyethylribonucleotides; P=S, phosphorothioate; PKC, protein kinase C; 2′- O-methyl, 2′- O-methoxyribonucleotides; mechanism of action; PKC-η; Antisense oligonucleotides; inhibition; CMV, cytomegalovirus; 2′- O-propyl, 2′-propoxyribonucleotides; splicing; research tools
• ISSN: 0163-7258; 1879-016X
• DOI: 10.1016/S0163-7258(99)00002-9

The dramatic increase in recent years of both the amount and rate of accumulation of novel genomic sequence information has generated enormous opportunities for the development of new classes of drugs. For these opportunities to be fully capitalized upon, investigators must choose molecular targets for drug development that are likely to yield attractive therapeutic profiles. This will require rapid and effective determination of gene functions in multiple cellular settings. The development of antisense oligonucleotides as specific inhibitors of gene expression should allow such determination of gene function. In addition, the antisense oligonucleotides themselves will likely prove useful as drugs. In this review, we discuss some of the issues surrounding the use of antisense oligonucleotides as research tools to help elucidate gene function, and highlight some of the approaches that can be taken to generate and use effective antisense reagents.